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Abstract
The Mycobacterium tuberculosis genome contains two large gene families encoding proteins of unknown function,
characterized by conserved N-terminal proline and glutamate (PE and PPE) motifs. The presence of a large number of PE/
PPE proteins with repetitive domains and evidence of strain variation has given rise to the suggestion that these proteins
may play a role in immune evasion via antigenic variation, while emerging data suggests that some family members may
play important roles in mycobacterial pathogenesis. In this study, we examined cellular immune responses to a panel of 36
PE/PPE proteins during human and bovine infection. We observed a distinct hierarchy of immune recognition, reflected
both in the repertoire of PE/PPE peptide recognition in individual cows and humans and in the magnitude of IFN-c
responses elicited by stimulation of sensitized host cells. The pattern of immunodominance was strikingly similar between
cattle that had been experimentally infected with Mycobacterium bovis and humans naturally infected with clinical isolates
of M. tuberculosis. The same pattern was maintained as disease progressed throughout a four-month course of infection in
cattle, and between humans with latent as well as active tuberculosis. Detailed analysis of PE/PPE responses at the peptide
level suggests that antigenic cross-reactivity amongst related family members is a major determinant in the observed
differences in immune hierarchy. Taken together, these results demonstrate that a subset of PE/PPE proteins are major
targets of the cellular immune response to tuberculosis, and are recognized at multiple stages of infection and in different
disease states. Thus this work identifies a number of novel antigens that could find application in vaccine development, and
provides new insights into PE/PPE biology.
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Introduction
The global public health and economic impact of infection with
Mycobacterium tuberculosis and the closely relatedMycobacterium bovis is
severe. Approximately 9.8 million new cases of M. tuberculosis
infections were estimated for 2010 [1], and recent years have seen
a rapid increase in M. bovis infections in the UK [2]. To curb the
spread of infection, improved therapeutic, diagnostic and pre-
ventative tools are urgently required. Such developments will be
underpinned by an improved understanding of pathogen biology
and host immunology.
A number of mycobacterial molecules have been implicated in
TB pathogenesis and shown to modulate host responses to
infection. These include members of the intriguing PE/PPE
protein families that are named for conserved proline-glutamate
(PE) and proline-proline-glutamate (PPE) motifs near their N-
termini [3]. These large protein families are especially abundant in
pathogenic mycobacteria, with almost 200 pe/ppe genes in both M.
tuberculosis and M. bovis [3,4]. The biological role of these proteins
remains elusive. Sequence homology-based inferences have shed
little light on their function, and structure-based predictions are
limited by the availability of only one experimentally determined
PE/PPE structure [5]. High-throughput phenotype screening
approaches have demonstrated that very few family members are
essential for in vitro growth or in vivo survival [6,7,8], which could
be indicative of functional redundancy. Speculation regarding the
function of these proteins abounds, and the identification of the
multi-member family prompted the suggestion that PE/PPE
proteins may act as variable antigens [3]. ‘‘Antigenic variation’’
usually refers to the phenomenon of regulated switching between
functionally conserved, but immunologically distinct, members of
a multigene family, which can aid in the avoidance of antigen-
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specific immune selection [9]. In particular, the highly poly-
morphic PE-PGRS (polymorphic GC-rich sequence) and PPE-
MPTR (major polymorphic tandem repeat) are speculated to aid
in immune avoidance in this way. Although this hypothesis has yet
to be experimentally verified, there are indications that PE/PPE
proteins may contribute to evasion of host immunity by other non-
mutually exclusive mechanisms [10]. For example, Ramakrishnan
and colleagues elegantly demonstrated that aMycobacterium marinum
pe-pgrs gene is required for granuloma persistence and survival in
macrophages [11]. As their name suggests, the PE-PGRS sub-
group of the PE family incorporates highly repetitive, variable C-
terminal domains, and it has been shown that these domains can
inhibit processing and subsequent antigenic presentation [12,13].
Others have demonstrated that selected PE/PPE family members
are involved in modulating cytokine secretion and other responses
(such as apoptosis and DC maturation) via interaction with toll-like
receptor 2 (TLR-2) [14,15,16,17]. Recently, deletion of a pe-pgrs
family member was shown to attenuate M. tuberculosis [18].
Available data therefore suggests that different PE/PPE proteins
may play distinct roles during infection, which are not yet fully
understood.
Some functional clues may be provided by the close genomic,
evolutionary and functional links between the pe/ppe genes and the
esx gene clusters [19]. The M. tuberculosis genome contains 5 esx
gene clusters, including the esx-1 locus, which encodes the ESX-1
secretion system. ESX-1, along with its best-studied substrates,
EsxA (ESAT-6, early secreted antigenic target of 6 kDa) and EsxB
(CFP-10, culture filtrate protein of 10 kDa), has been implicated in
mycobacterial virulence [20,21,22]. A subset of the PE/PPE
protein family is encoded as co-transcribed pe/ppe gene pairs,
embedded within the esx-1, -2, -3 and -5 regions, immediately
upstream of an esxB/esxA paralogous pair ([19], Figure S1). These
will subsequently be referred to as pe/ppe genes from complete esx
clusters. Another 5 pe/ppe gene pairs are found immediately
adjacent to an esxB/esxA gene pair with no other esx-region genes
([19], Figure S1); these will be referred to pe/ppe genes from partial
esx clusters. Finally, there are 8 examples of isolated pe/ppe gene
pairs, with no adjacent esx genes ([19], Figure S1). Multi-genome
comparisons and phylogenetic analysis suggests that pe/ppe
evolution and expansion is closely linked with that of the esx gene
clusters ([19]). Furthermore, an apparent functional link between
the PE/PPE families and the ESX secretion systems has been
elucidated; a series of studies suggests that the secretion of a large
number of PE/PPE proteins in M. marinum is ESX-5-dependent
[23,24,25]. More recently, it has been demonstrated that the M.
tuberculosis ESX-5 region is required for the secretion of PPE41
[26]. Although it is not yet known whether their localization is
always ESX-mediated, cell wall association and/or secretion have
been demonstrated for several PE/PPE family members [10].
Importantly, cell surface exposure and secretion into the
extracellular milieu places these proteins in an ideal position to
interact with host cell components and in particular to evoke T cell
responses.
Selected members of these families have been shown to elicit
robust immune responses in infected hosts. PE/PPE proteins
elicit cellular and/or humoral responses [10], leading to
suggestions that they be further evaluated as possible vaccine
and diagnostic candidates. Indeed, the subunit vaccine candi-
date Mtb72F, currently undergoing clinical trials, is based on
a chimeric fusion of a PPE (Rv1196/PPE18) protein with
a protease [27,28,29,30]. However, studies to date have tended
to investigate only a limited number of PE/PPE proteins, and
this lack of a systematic approach limits our overall un-
derstanding of the immunogenic potential of these proteins. To
address this shortcoming, we performed comprehensive analysis
of the immunogenicity of 36 PE/PPE proteins in cattle infected
with M. bovis and in M. tuberculosis-infected humans, both of
which represent infections in their natural hosts. We have
identified a large number of immunogenic PE/PPE-derived
peptides, and show that antigenic cross-reactivity is associated
with immune recognition of PE/PPE proteins. Our results
demonstrate a similar immune recognition hierarchy in humans
and cattle, and provide insight into the biology of these
intriguing proteins.
Results
PE/PPE Protein Selection
A total of 36 PE/PPE proteins were selected for this study:
10 of these were encoded by pe/ppe genes within complete esx
regions (esx-1,-2,-3 and -5); 10 were encoded by pe/ppe genes
from partial esx clusters, adjacent to esxB/esxA homologues (but
with no other adjacent esx region genes), and 16 were encoded
by isolated pe/ppe pairs (Table 1, Figure S1). We had previously
demonstrated that this subset of PE/PPE proteins encoded
within esx, partial esx and non-esx genomic locations represented
4 phylogenetic sub-groups ([19], Figure S2). The rationale
behind this selection was to allow analysis of a diverse cross-
section of the PE/PPE family.
Peptides (n = 1043) were designed based on the M. tuberculosis
H37Rv protein sequences, and with the exception of one PE/
PPE pair, all of the proteins selected for this study were present
in Mycobacterium bovis (Table 1). The protein pair PE32/PPE65 is
encoded within a 5894 bp region in M. tuberculosis H37Rv which
is deleted in M. bovis, thus these orthologues are not present in
M. bovis. Twenty-three proteins selected for the study were
100% identical in the two species (Table 1). Mutations identified
in the remaining 11 proteins are summarized in Table 1. In
total, these differences affected only 30 peptides in 12 pools.
(Table S1). We therefore concluded that the peptide library
based on M. tuberculosis H37Rv was suitable for use in both
species.
PE/PPE Immune Recognition in M. bovis-infected Cattle
To gain an overview of the degree of immunogenicity of the
PE/PPE proteins selected for this study, we first performed a cross-
sectional study in cattle experimentally infected with M. bovis.
Samples were obtained from 17 animals at 12–14 weeks post-
infection, and recall immune responses to peptide pools corre-
sponding to 36 PE/PPE proteins were analyzed. Whole blood was
stimulated with 101 pools of 8–12 peptides per pool (n = 1043 total
peptides), and IFN-c production was measured by ELISA. This
approach identified a striking number of immunogenic PE/PPE
peptide pools (Figure 1A). Sixty-five peptide pools elicited a positive
response in 2 or more animals. Fifteen pools, representing 9
different PE/PPE proteins, were recognized in $50% of
experimentally infected cattle (Figure 1B, Table 2, Table S1).
Ten animals (58.8%) recognized$20 pools each (mean number of
pools recognized, 23.1; SD, 16.2; range, 57). Notably, in 9 skin-test
and Bovigam-negative animals tested prior to experimental
infection, no response to any of the PE/PPE peptide pools was
detected (data not shown), indicating the specificity of these
immune responses.
Bioinformatic, phylogenetic and functional analyses have
revealed a close association between PE/PPE proteins and the
ESX regions [19]. Recent evidence suggests that several PE/PPE
proteins are secreted by the ESX apparatus [23,24,25], which may
render them more likely to be immunogenic. We compared the
PE/PPE Immunogenicity
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recognition of PE/PPEs originating from different ESX groupings
(Figure S1, Table 1), to determine whether these were differen-
tially immunogenic. Peptide pools representing the PE/PPE
proteins encoded by partial esx clusters were significantly more
immunogenic, with 23/27 (79.3%, p = 0.0096, Fisher’s exact test)
of these eliciting positive responses in 2 or more infected cattle
compared to peptide pools representing isolated PE/PPE pairs
and complete ESX clusters (56.7%, 42/74). These results indicate
that genomic association with a complete esx cluster is not
a prerequisite for immune recognition.
M. tuberculosis-infected Humans Demonstrate a Similar
PE/PPE Immune Recognition Hierarchy to M. bovis-
infected Cattle
We performed a second cross-sectional study to assess PE/PPE
immunogenicity in humans with activeM. tuberculosis infection. For
this, we selected 21 pools that were recognized in $40% cattle,
plus an additional 7 pools corresponding to adjacent PE proteins
or downstream pools from the same PPE protein (Table 2). Once
again, a striking number of immunogenic pools were identified. A
total of 14/28 pools were recognized in $50% individuals. Ten
Table 1. PE/PPE proteins selected for this study.
Rv number PE/PPE ESX associationa # peptides (# pools) M. bovis sequence comparison
Rv0285 PE5 C 12 (1) Identical
Rv0286 PPE4 C 63 (6) Identical
Rv0915c PPE14 I 52 (5) Identical
Rv0916c PE7 I 11 (1) Identical
Rv1039c PPE15 P 48 (5) Identical
Rv1040c PE8 P 33 (3) Identical
Rv1168c PPE17 I 42 (4) Frameshift in M. bovis, otherwise identical
Rv1169c PE11 I 11 (1) Identical
Rv1195 PE13 P 11 (1b) Identical
Rv1196 PPE18 P 48 (5) R235L, M249V, A275del, Q279E
Rv1386 PE15 I 12 (1) Identical
Rv1387 PPE20 I 66 (6) V94A
Rv1787 PPE25 C 45 (4) S309del,V311G
Rv1788 PE18 C 11 (1) Identical
Rv1789 PPE26 C 48 (5) S274A
Rv1790 PPE27 C 10c (1) P190S
Rv1806 PE20 I 11 (1) Identical
Rv1807 PPE31 I 48 (5) F223S, V234L
Rv2107 PE22 I 11 (1) Identical
Rv2108 PPE36 I 29 (3) Identical
Rv2430c PPE41 I 23 (2) Identical
Rv2431c PE25 I 11 (1) Identical
Rv2768c PPE43 I 47 (5) P263R
Rv2769c PE27 I 33 (3) P54S, V270M
Rv3018A PE27A P 1 (1b) Identical
Rv3018c PPE46 P 19c (2) Identical
Rv3021c PPE47 P 44 (1) G222A, L240V, A242T
Rv3022A PE29 P 11c (1) Identical
Rv3477 PE31 I 11 (1) Identical
Rv3478 PPE60 I 48c (5) Identical
Rv3621c PPE65 P 51 (5) Deleted in M. bovis
Rv3622c PE32 P 11 (1) Deleted in M. bovis
Rv3872 PE35 C 11 (1) Identical
Rv3873 PPE68 C 45 (4) Identical
Rv3892c PPE69 C 49 (5) T19K
Rv3893c PE36 C 9 (1) Identical
a. C, PE/PPEs encoded by complete esx gene cluster; P, PE/PPE encoded by partial esx cluster; I, PE/PPE encoded by isolated pe/ppe pair (see Figure S1).
b. Single peptide for Rv3018A/PE27A mixed with PE13 set.
c. Pool does not include all possible overlapping peptides, some were excluded due to 100% identity.
doi:10.1371/journal.pone.0040890.t001
PE/PPE Immunogenicity
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individuals (58.8%) recognized $10 pools each (mean number of
pools recognized, 12.0; SD, 8.3; range, 22).
We then compared immune recognition in the two species. This
revealed a similar immune recognition hierarchy in cattle and
humans exposed to M. bovis and M. tuberculosis, respectively
(Figure 2, Table 2). Ten pools were recognized in $50% of
individuals for both species. There was a statistically significant
correlation between responses in humans and cattle, both as
Figure 1. IFN-c responses to PE/PPE peptide pools in experimentally infected cattle.Whole blood from cattle experimentally infected with
36103 CFU M. bovis AF2122/97 was stimulated with pools of peptides representing 36 PE/PPE proteins at 12–14 weeks post-infection. IFN-c
production was assessed by the ELISA-based Bovigam assay. (A) IFN-c responses to 101 PE/PPE peptide pools in experimentally infected cattle
(n = 17) expressed as OD450– Nil antigen well reading (DOD450). Grey box highlights responses to PE/PPE peptides derived from PE/PPE proteins
encoded by partial esx regions. Peptides derived from PE/PPE proteins from complete ESX regions and those encoded as isolates PE/PPE pairs are also
indicated. Responses to an EsxA/B peptide cocktail are also shown for comparison. (B) Twenty-five PE/PPE pools that elicited positive responses in
$40% cattle tested, ranked according to proportion responders.
doi:10.1371/journal.pone.0040890.g001
PE/PPE Immunogenicity
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measured by proportion responders (Figure 2) and mean responses
(data not shown).
Disease Status does not Alter the PE/PPE Immune
Recognition Hierarchy
The results described above revealed a very similar PE/PPE
immune recognition hierarchy in humans and cattle with TB.
However, in both species, samples were obtained from individuals
with active disease, which could bias responses towards a particular
immune profile. We therefore determined whether differences in
disease status or stage impacted on the immune response to these
proteins. We first compared immune responses to PE/PPE peptide
pools in humans with active and latent infection. Overall, a similar
PE/PPE immune hierarchy was observed for these 2 groups
(Figure 3A). No statistically significant difference was observed
between the magnitude of IFN-c responses of active and latent
cases for any of the PE/PPE pools tested (Figure 3B and data not
shown).
To further assess the impact of disease stage on PE/PPE
immune recognition, we performed a prospective study to
examine the kinetics of immune responses to PE/PPE peptide
pools over a 16 week course of infection in cattle. Representative
data is shown for one animal in Figure 4. From 2–3 weeks post-
infection onwards, positive responses to the control antigens PPD-
B, PPD-A and the EsxA/B peptide cocktail were detected (Fig 4A).
As we have previously observed [31,32], the magnitude of IFN-c
responses fluctuated over time, likely reflective of the dynamic
nature of the circulating peripheral immune cell population.
Responses to PE/PPE peptide pools followed similar kinetics to
responses to control antigens. Representative response profiles are
shown for peptide pools representing 3 PE/PPE pairs in Figure 4B-
D. In total, for the animal shown in Figure 4, 20/101 peptide
pools were recognized as early as 2 weeks post-infection (Figure 4B-
D and data not shown). An additional 15 peptide pools were
recognized at 4 weeks post-infection. Responses to the 35
recognized peptide pools were then sustained at subsequent time
points (14 and 16 weeks post-infection). It therefore appears that
under the experimental conditions employed, the set of PE/PPE
pools which is recognized does not substantially alter over the
course of the infection. A similar trend was observed for an
additional 4 animals tested (data not shown); once a PE/PPE
peptide pool was recognized, the response towards that pool was
observed at all later time points. In addition, a similar immune
recognition profile was observed in naturally infected cattle (data
not shown, Table S2). In summary, recognition of particular PE/
PPE proteins occurred early and was sustained throughout the
course of infection as well as in different disease statuses.
Table 2. Bovine and human responses to selected PE/PPE
peptide pools.
Cattle Humans
Pool % respondersa
Mean
DOD450 % responders
a
Median
SFC
PPE18_B 88.2 0.52 58.8 28
PE13_A 82.4 0.72 52.9 20
PPE18_A 82.4 0.72 70.6 24
PPE20 A 80.0 0.41 64.7 28
PPE18_C 70.6 0.39 29.4 8
PPE26_A 70.6 0.33 47.1 12
PPE60_A 68.8 0.51 52.9 20
PPE20 B 66.7 0.35 64.7 28
PE31_A 64.7 0.4 52.9 20
PE18_A 62.5 0.22 58.8 36
PPE69_B 62.5 0.30 36.4 4
PPE26_B 56.3 0.20 58.8 29
PPE69_D 53.3 0.27 70.6 48
PPE69_C 52.9 0.34 58.8 20
PPE65_B 50.0 0.14 ND ND
PPE60_B 47.1 0.26 64.7 32
PPE69_E 47.1 0.26 58.8 32
PPE60_C 46.7 0.36 41.2 12
PPE47_A 43.8 0.20 ND ND
PPE18_D 41.2 0.22 5.9 0
PE15 A 41.2 0.34 17.6 8
PPE26_C 41.2 0.13 35.3 8
PE20_A 41.2 0.14 5.9 0
PPE31_B 41.2 0.23 ND ND
PPE46_B 40.0 0.37 ND ND
PPE60_D 35.3 0.25 35.3 5
PPE18_E 29.4 0.14 17.6 4
PPE26_E 26.7 0.11 11.8 0
PPE60_E 23.5 0.25 47.1 16
PE36_A 13.3 0.04 52.9 20
PPE69_A 13.3 0.05 41.2 12
PPE26_D 5.9 0.01 0.0 0
ESX 100.0 2.21 70.6 56
a. Individual cattle samples were scored as positive if DOD450 values were $0.1,
and human samples were scored as positive if $20 SFC were counted per 106
PBMC.
doi:10.1371/journal.pone.0040890.t002
Figure 2. Comparison of proportion responders in human and
bovine hosts with active TB. Responses to 28 PE/PPE peptide pools
were assessed in both cattle and humans with active TB, by Bovigam or
ELISPOT assays. Individual cattle samples were scored as positive if
DOD450 values were $0.1, and human samples were scored as positive
if $20 SFC were counted per 106 PBMC. Linear regression analysis
produced the line shown. A Pearson correlation test revealed
a statistically significant correlation between the proportion human
responders and the proportion bovine responders; r(26) = 0.539, 2-
tailed p value = 0.0031.
doi:10.1371/journal.pone.0040890.g002
PE/PPE Immunogenicity
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Conserved N-terminal Domains are More Immunogenic
Analysis of bovine and human immune responses to PE/PPE
peptide pools highlighted a trend towards better recognition of N-
terminal peptide pools. For example, in the 3 representative
examples shown in Figure 4 B–D, N-terminal peptide pools
elicited larger IFN-c responses, as measured by DOD450. We
Figure 3. Immune responses to PE/PPE proteins in humans with active and latent infection. PBMC from M. tuberculosis-sensitized
individuals were stimulated with PE/PPE peptide pools, and IFN-c producing cells were enumerated by ELISPOT. (A) Proportion responders to all PE/
PPE pools analyzed. Grey bars, individuals with latent infection; Black bars, individuals with active infection. (B) Number of IFN-c producing cells
measured after stimulation with PE/PPE peptide pools. White symbols, individuals with latent infection; Black symbols, individuals with active
infection. No statistically significant differences were observed between responses in individuals with latent and active infection for any of the
peptide pools analyzed (as determined by Mann Whitney U test). Results for a representative set of pools shown, horizontal lines indicate median
responses.
doi:10.1371/journal.pone.0040890.g003
PE/PPE Immunogenicity
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examined this further by plotting combined data for all PE and
PPE pools across the length of the proteins. The shorter PE
proteins were represented by a single pool, whereas the longer
PPE proteins were represented by up to 6 pools. The immuno-
genicity of the peptide pools both as measured by the proportion
responders (Figure 5A) and magnitude of responses (data not
shown), decreased across the length of the protein. As previously
noted, the N-terminal regions of the PE/PPE proteins are
relatively conserved. We observed a statistically significant
correlation between the degree of sequence conservation and
immune recognition (Figure 5B). This data therefore indicates that
the most conserved regions of these proteins are most likely to elicit
an immune response.
Antigenic Cross-reactivity is Associated with Immune
Recognition
The results described above suggested that the immune
responses observed were associated with immunological cross-
reactivity towards the relatively conserved PE/PPE N-terminal
domains. To examine in detail whether responses were directed
towards epitopes situated in the most conserved regions, we
characterized responses to individual peptides within selected
pools. We first measured responses to 258 constituent peptides
from 26 pools that had elicited positive responses in cattle.
Responses to individual peptides were examined in up to 5
animals. For all pools, at least 1 peptide that elicited a positive
response was identified. Up to 8 (median = 2.5) peptides/pool
were recognized. A total of 97 individual positive peptides were
identified (Table S1).
To assess the extent of potential cross-reactivity, sequence
comparisons between the peptides eliciting positive responses and
other PE/PPE proteins were performed. This underscored the
tendency for recognition of the most conserved peptides, which
could potentially harbor cross-reactive epitopes. As illustrated in
Figure 6, the peptides which elicited positive responses showed
.70% amino acid identity to at least one, and frequently multiple,
Figure 4. Temporal profile of bovine IFN-c responses to PE/PPE peptide pools. IFN-c responses were measured following stimulation of
whole bovine blood with PE/PPE peptides and control antigens before, and at multiple time points following, experimental infection of cattle with M.
bovis AF2122/97. (A) Responses to controls antigens; avian PPD (PPD-A), bovine PPD (PPD-B) and an EsxA/B peptide cocktail. (B) to (D) Representative
responses to sets of PE/PPE peptide pools. Open grey symbols, PE pools; Solid black symbols, PPE pools;&, m, .,¤, N, pools A-E, respectively (B)
IFN-c responses to PE18/PPE26 peptide pools. (C) IFN-c responses to PE31/PPE60 peptide pools. (D) IFN-c responses to PE8/PPE15 peptide pools.
Mean responses for a single representative animal are shown.
doi:10.1371/journal.pone.0040890.g004
PE/PPE Immunogenicity
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independent PE/PPE proteins. This trend was typical of other
peptides examined, with 70 of the 97 positive peptides showing
.70% amino acid sequence homology to 1 or more additional PE
or PPE regions (Table S1). This suggests that the immune response
to these peptides is partly attributable to recognition of cross-
reactive epitopes.
A high degree of sequence identity alone does not necessarily
guarantee T cell cross-reactivity, and even single amino acid
substitutions can alter MHC binding or T cell recognition of the
epitope. Therefore, we further examined the functional con-
sequences of sequence variation in different PE/PPE proteins in
short-term bovine T cell lines. In these experiments, we performed
an initial expansion of antigen-specific T cell clones with a selected
peptide in the presence of IL-2. The expanded clones were
restimulated either with the original peptide, or with a second non-
identical, but similar, peptide. Responses were then assessed by
measuring IFN-c production. In these experiments, if T cell cross-
reactivity occurred, we would expect non-identical, but similar,
peptides to elicit IFN-c production upon secondary stimulation of
the T cell lines. In the first example, T cells were expanded by
primary stimulation with peptide PE31_10 (Figure 7A). As
expected, IFN-c was produced upon restimulation with this
peptide. In contrast, no detectable IFN-c was produced upon
restimulation with PE32_10, which shares 13 residues with
PE31_10. However, restimulation with PE13_10 (which has 4
amino acid differences when compared to PE31_10) elicited
a detectable response. This indicates that there is cross-recognition
of PE13_10 by the PE31_10-expanded T cell population.
Cross-reactivity was further assessed for PPE-expanded T cell
lines, and we observed similar results for T cell lines established by
primary stimulation with either PPE18_14 or PPE60_14
(Figure 7B and 7C, respectively). These peptides are themselves
85% identical, and PPE18_14-expanded T cell lines responded to
PPE60_14 and vice versa. PPE18_14-expanded lines also
responded to the corresponding peptides from PPE65
(PPE65_14, 15/20 residues identical) and PPE25 (PPE25_14,
12/20 residues identical). Stimulation with PPE31_14 elicited low
IFN-c responses in PPE18_14-established cell lines (Figure 7B),
and no detectable response in PPE60_14-expanded lines
(Figure 7C), suggesting that critical MHC-binding or T cell
recognition residues were altered. Importantly, despite multiple
amino acid changes, 3 out of 4 peptides derived from PPE proteins
other than PPE18 elicited IFN-c responses above the cut-off of 0.1
for PPE18_14-derived lines. This supports the interpretation that
the recall immune responses observed in this study are partially
driven by cross-reactive T cells.
Discussion
To address gaps in our understanding of the PE/PPE proteins
and their role in infection, we examined immune responses to
a large subset of PE/PPE proteins. The 36 proteins selected for
this study represented a diverse cross-section of the PE/PPE
protein families. We assessed PE/PPE immunogenicity in two host
species, namely cattle infected with M. bovis and humans infected
with M. tuberculosis. These both represent mycobacterial infections
in natural hosts, and offer the opportunity to investigate immune
responses to mycobacterial antigens. We first performed high-
throughput screening of infected cattle for immunological re-
sponsiveness to 1043 peptides representing 36 PE/PPE proteins. A
striking number of peptide pools elicited IFN-c production,
indicating sensitization of the cattle to PE/PPE proteins. In total,
peptides representing 9 PE/PPE proteins elicited positive
responses in $50% of infected cattle. Seven of these had not
been previously described in the literature. This work therefore
Figure 5. Immune recognition correlates with sequence conservation. (A) IFN-c responses were measured following stimulation of whole
bovine blood with PE/PPE peptide pools, and scored as positive if DOD450 values were $0.1. The proportion of responders was plotted along the
length of the PE/PPE proteins, where A corresponds to the peptide pool closest to the N-terminal. *, 2-tailed p value ,0.05 (unpaired t-test). The
letters A to F denote the position of the peptide pool across the length of the protein, with A nearest the N-terminal. PE_A represents the conserved
110 aa region, while PPE_A and PPE_B encompasses the conserved 180 aa region of the PPE proteins. (B) The proportion responders to PE/PPE
peptide pools was plotted against % identity, which corresponds to the % identity of the amino acid sequence corresponding to that pool to its
closest match in the M. tuberculosis genome sequence. Linear regression analysis produced the line shown. A Spearman correlation test indicated
revealed a statistically significant correlation between % identity and proportion bovine responders; rho(98) = 0.401, 2-tailed p value ,0.0001.
doi:10.1371/journal.pone.0040890.g005
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substantially advances our knowledge of the high immunogenic
potential of the PE/PPE proteins.
A subset of peptide pools was assessed in human TB patients,
and confirmed the highly immunogenic nature of these proteins.
Furthermore, this revealed a very similar hierarchy of immuno-
dominance (where this refers to peptide pools that are most
frequently recognized) in bovine and human hosts. Although PE/
PPE proteins are considered to be among the most variable
members of the mycobacterial proteome, it should be noted that it
is predominantly the PE-PGRS and PPE-MPTR family members
that this applies to, and the subset of PE/PPE proteins selected for
this study were in fact relatively conserved. Twenty-three of the 36
proteins examined here were identical in M. bovis AF2122/97 and
M. tuberculosis H37Rv. For the remainder, the differences observed
were predominantly single point mutations. Similar results were
observed for 27 clinical isolates of M. tuberculosis for which
complete genome sequences were available (data not shown). It
could therefore be argued that a similar immune recognition
hierarchy is unsurprising. Nonetheless, 2 recent publications
reported that several pe/ppe genes are differentially transcribed in
M. bovis andM. tuberculosis [33,34], 6 of which were included in this
study. This, together with the differing host tropisms of the 2
Figure 6. Whole blood IFN-U responses to individual and pooled PE/PPE peptides. Peptide pools eliciting positive responses were further
analysed by assessing the contribution of each constituent peptide at 3, 5 or 9 weeks post-infection. Representative data are shown for peptides
corresponding to (A) One pool derived from PE8, and (B) One pool derived from PPE15. The solid lines represent the temporal response to a peptide
pool, while individual symbols correspond to individual peptides. (C) and (D) BLASTP homology searches were performed with peptides which
elicited positive responses, and closest matches are shown in a CLUSTALW alignment.
doi:10.1371/journal.pone.0040890.g006
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species could suggest that differential expression and/or recogni-
tion of PE/PPE proteins might occur. Despite this, we still
observed a similar immune recognition hierarchy.
The initial part of this study was performed in cattle and human
hosts with active TB, which could imply that the observed
hierarchy of immune recognition is only reflective of uncontrolled
infection. However, similar results were obtained when we
compared immune responses in humans with active or latent
infections, in naturally infected cattle (Table S2) and at multiple
time points over a 4-month course of disease in experimentally
infected cattle. This indicates that numerous PE/PPE family
members are expressed and recognized throughout infection,
potentially playing an important functional role.
The immune recognition data presented here raises questions
regarding the mechanisms underlying differential PE/PPE immu-
nogenicity. One simple explanation could be that there is
differential expression of PE/PPE family members during in-
fection. At the mRNA level, there are indications of differential pe/
ppe gene expression in vitro [35]. However, in vivo analysis is more
challenging. Analysis of transcriptional profiles of M. tuberculosis
isolated from human pulmonary tissue demonstrated that several
PE/PPE proteins are indeed upregulated upon infection
Figure 7. IFN-c responses of short-term T cell lines to potentially cross-reactive PPE peptides. Short-term T cell lines were raised by
primary stimulation of bovine PBMC with individual PE or PPE peptides in the presence of IL-2. Following initial expansion with (A) PE31.10, (B)
PPE18.14 or (C) PPE60.14, cells were re-stimulated with selected peptides, predicted to be immunologically cross-reactive. IFN-c production was then
measured using the ELISA-based Bovigam assay. The amino acid sequence of the initial stimulation peptide is shown in alignment with restimulation
peptides, with amino acid substitutions indicated. Responses are shown as DOD450 values, and the dashed line indicates the positivity cut-off value of
0.1.
doi:10.1371/journal.pone.0040890.g007
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[36,37,38], but there is no clear correlation between these and the
immunogenic rank of antigens identified in this study. mRNA
levels do not necessarily translate to antigen abundance, and
methods for measuring in vivo protein levels are technically limited.
One recent study attempted to characterize the in vivo M.
tuberculosis proteome by large-scale LC-MS [39]. Interestingly, this
approach identified several of our top-ranking PE/PPE proteins in
guinea pig lungs at 90 days post-infection, suggesting that
immunogenicity could in part be enhanced by higher protein
expression levels. However, this proteomic approach is not
comprehensive and further investigation will be required to
determine whether there is a direct correlation between protein
abundance and immunogenicity.
Previous studies have shown that secreted proteins tend to be
immunogenic [40]. Several PE/PPE proteins are known to be
secreted [10], and there are indications that this could be ESX-
mediated [23,24,25,26,41]. We recently assessed the immunoge-
nicity of a panel of predicted secreted antigens, including EsxB/
EsxA orthologues [41]. The top-ranking antigens identified in that
study included EsxA and/or EsxB homologues from 2 complete
and 4 partial esx clusters. In the present study, pools representing
the PE/PPE proteins encoded upstream of these esxA/esxB
orthologues were recognized in $30% of infected cattle.
Furthermore, we found that PE/PPE proteins encoded by partial
ESX clusters were significantly more immunogenic than those
from complete ESX clusters. As previously noted, this indicates
that association with a complete ESX cluster is not required for
immune recognition. As the complete ESX cluster is expected to
be necessary for secretion [42], this raises the interesting possibility
that there could be cross-talk between ESX clusters, with the
secretion of PE/PPE proteins mediated by ESX clusters encoded
at genomically distal locations.
Further factors which could influence PE/PPE immunogenicity
are MHC binding and T cell recognition of the MHC II-peptide
complex. Bioinformatic analysis revealed no particular bias toward
higher epitope density in the more immunogenic peptide pools
(data not shown). However, the accuracy of current MHC II-
binding prediction methods is limited, and does not take into
account T cell recognition. Although experimental assessment of
MHC II binding was beyond the scope of this study, we note that
a large proportion of peptide pools were recognized in hosts from
2 different species and with diverse MHC repertoires. This
indicates that the PE/PPE peptide library examined could include
several promiscuous epitopes, and suggests that these may be
promising vaccine candidates.
This study suggests that similar PE/PPE family members are
expressed and recognized at different stages of infection. Even if
different members of this subset were expressed at different time
points, our results indicate that cross-reactive, PE/PPE-directed T
cell populations are present throughout infection. As T cell
responses appear to be primarily targeted towards the most
conserved regions of the PE/PPE proteins, these would be
expected to recognize multiple PE/PPE family members. The
circulating T cell population might be slower to respond (i.e.
antigen-specific effector cells could still be present even if the
particular antigen is no longer expressed), and subtle changes may
not be detected with the approaches used in this study. However,
previous work suggests that T cell responses are reflective of
antigen load [43], and would be expected to wane in the absence
of a particular antigen. In contrast, we observed increasing
magnitudes of T cell responses at later time points, providing an
indirect indication that the antigens are still being expressed.
This work suggests that immunological cross-reactivity occurs in
a significant proportion of the observed PE/PPE immune
responses. We showed that peptide pools corresponding to the
most conserved regions of the proteins are most likely to elicit IFN-
c production. This is best illustrated by the example of PE32/
PPE65, for which the genes are deleted in M. bovis. However,
PPE65 shows a high degree of similarity to several other PPE
proteins, and one peptide pool (PPE65_B) derived from this
protein is recognized by 50% of bovine hosts (Table 2, Table S1).
Furthermore, at the individual peptide level, peptides that elicited
positive responses also demonstrated high degrees of sequence
conservation. The idea that immune recognition is reflective of
cross-reactivity was further corroborated with short-term bovine T
cell lines raised by primary stimulation with a particular PE or
PPE peptide. These produced IFN-c in response to stimulation
with peptides corresponding to other PE/PPE proteins, highlight-
ing that even altered amino acid sequences were able to elicit recall
responses. Together, these results suggest that even if different PE/
PPE variants were expressed, this would likely be an ineffective
immune escape mechanism, due to extensive T cell cross-
reactivity.
A recent report which combined analysis of multiple genome
sequences with immunogenicity data demonstrated an unexpect-
edly high level of conservation of human T cell epitopes [44].
Unfortunately, due to inherent technical limitations of the
sequencing methodology, PE/PPE proteins were excluded from
that analysis. While it is possible that some members of these
protein families may prove an exception to that finding, the subset
studied here appears to be relatively conserved both within and
between species. The work described here adds another dimension
and shows that even when PE/PPE amino acid sequences do vary,
this does not necessarily impair epitope recognition. This suggests
that even the unexpectedly high degree of epitope conservation
calculated by Comas et al [44] may underestimate conservation at
the level of the immune response.
A limitation of this study is that we have not assessed immune
responses to any representatives of the PE_PGRS or PPE_MPTR
subgroups. These family members possess highly repetitive
domains that exhibit substantial genetic variation
[3,12,45,46,47], and may be differentially recognized. It has
previously been demonstrated that the conserved PE domain of
PE_PGRS33 elicited primarily Th1-type responses [48], and we
recently showed that T cell responses were predominantly directed
towards the non-conserved region of PE_PGRS62 (Rv3812) [49].
This underscores the complexity of the immune response to these
antigens and suggests that further systematic analysis of immune
responses to these PE/PPE subgroups will be required to establish
the functional and immunological consequences of the observed
variation within their C-terminal domains. In future work, it
would be of interest to perform a comprehensive analysis of these
subgroups.
Measuring IFN-c production alone provides a relatively isolated
assessment of the immune response. In future work, a more
detailed phenotypic characterization of responding cell popula-
tions and measurement of cytokines other than IFN-c should be
undertaken. Together with systematic, high-throughput analysis of
responses to other PE/PPE family members, such as those from
the PE_PGRS and PPE_MPTR subsets, this could help to unravel
the cumulative impact of PE/PPEs on host immune responses.
As discussed by others [44,50], immune recognition and
subsequent host responses are not necessarily detrimental, and
may indeed be beneficial, for pathogenic mycobacteria. In this
study, PE/PPE proteins were recognized at all stages of disease,
including in individuals with asymptomatic infections. This
suggests that they provide some benefit for the bacterium to
balance the cost of maintaining these large gene families. One
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possibility is that the robust T cell responses they elicit could
promote tissue damage and subsequent transmission. An alterna-
tive hypothesis is that PE/PPE proteins could act as decoy
antigens, overwhelming and mis-directing immune responses,
thereby preventing the priming of potentially protective T cell
populations. A further possibility is that these proteins play some
other, yet-to-be elucidated, role in mycobacterial pathogenesis.
In summary, we report here on the most comprehensive
analysis of PE/PPE immunogenicity to date, in two different host
species. The 36 PE/PPE proteins examined here were selected
from 4 different phylogenetic sub-groups, and therefore repre-
sented a large cross-section of the two protein families. We have
shown that the PE/PPE proteins are highly immunogenic, and
demonstrate a similar immune recognition hierarchy in different
species and at different stages of infection. This work shows that
PE/PPE-specific immune responses are largely driven by cross-
reactivity. Some of the antigens that have been newly identified
here could be useful as future vaccine candidates. However, any
such initiatives should be accompanied by work to improve our
understanding of which epitopes elicit protective immune
responses, rather than inadvertently providing further benefit to
the bacterium.
Methods
Ethics Statement
The study was approved by the University of Cape Town
Research Ethics Committee (REC249/2009) and written in-
formed consent was obtained from all human study participants.
All bovine work was carried out in accordance with the UK Home
Office Animal (Scientific Procedures) Act 1986, following approval
by the AHVLA Ethical Review Board and the UK Home Office.
Peptide Design, Synthesis and Preparation
36 PE/PPE proteins associated with, or duplicated from ESX
clusters (Figure S1, [19]) were selected for study. Mycobacterium
tuberculosis H37Rv amino acid (aa) sequences were used to design
a library of 20 aa long peptides with a 12 residue overlap. In silico
analysis was performed to identify duplicate peptides; exact
duplicates were eliminated (Table S1), resulting in a final set of
1043 peptides. Peptides were prepared using multirod peptide
synthesis (Pepscan systems, The Netherlands), and subjected to
HPLC/MS to confirm purity. Lyophilized peptides were resus-
pended in Hanks balanced salt saline solution (HBSS) with 10%
DMSO at 4 mg/ml. Peptides were used in assays at 5 mg/ml,
either as individual peptides or in pools of 8–12 peptides per pool.
Peptides from ESAT-6 (EsxA) and CFP-10 (EsxB) were synthe-
sized by conventional solid-phase synthesis technology, and the
EsxA/B peptide cocktail was prepared as previously described
[51].
Experimental Animals
Approximately six month-old male Holstein or Holstein cross
calves were obtained from herds free of bovine tuberculosis (BTB),
and were housed in appropriate biological containment facilities at
AHVLA. Calves (n = 17) were infected via the intratracheal route
with 36103 CFU Mycobacterium bovis field isolate AF2122/97.
Infection status was confirmed by single intradermal comparative
cervical test (SICCT, [52]) and in vitro IFN-c release assays. In
addition, all animals presented with visible lesions and were
culture positive when post-mortem examinations were carried out
at approximately 4 months post-infection. Heparinized blood
samples were collected before and at multiple time points
following infection.
Bovigam IFN-c Release Assay
Bovigam (Prionics AG, Switzerland) assays were performed
according to the manufacturer’s instructions. Briefly, heparinized
bovine blood was collected, and whole blood cultures were
initiated on the day of sampling. Blood cells were stimulated with
control antigens or peptides for 48 h. Controls included: no
antigen, 10 mg/ml of avian or bovine purified protein derivative
(PPD) (Veterinary Laboratories Agency (VLA), United Kingdom)
and 1 mg/ml pokeweed mitogen (SIGMA). Peptides were used at
a final concentration of 5 mg/ml for each peptide. Following
stimulation, plasma supernatants were harvested and stored at
280uC until further processing. IFN-c levels were quantified using
an ELISA-based assay performed with reagents supplied with the
kit. As for previous studies [40,41,51], results were scored as
positive if the optical density at 450 nm (OD450) minus the OD450
without antigen was $0.1 in both of the duplicate wells.
Short-term Bovine T cell Lines
Peripheral blood mononuclear cells (PBMC) were isolated from
heparinized bovine blood by Histopaque-1077 (SIGMA) density
gradient centrifugation. PBMC were washed in HBSS containing
heparin, then in RPMI 1640 tissue culture medium (Life
Technologies, United Kingdom) supplemented with 10% fetal
calf serum (SIGMA), nonessential amino acids (SIGMA),
561025 M b-mercaptoethanol, 100 U/ml penicillin, and
100 mg/ml streptomycin sulphate (subsequently referred to as
RPMI complete). Isolated PBMC were then used to set up short-
term T cell lines or cultured antigen presenting cells (APC). APC
were prepared by setting up 96 well plates with 16106 cells/well,
then incubating at 37uC, 5% CO2 for 2 hours. Plates were washed
3 times with HBSS to remove non-adherent cells. The remaining
adherent cells were incubated with RPMI complete at 37uC, 5%
CO2 for 15 days, and then used for secondary antigen stimulation
with cultured T cell lines. To generate T cell lines, PBMC were
added to 24 well plates at 16106 cells/well. PBMC were incubated
with 5 mg/ml primary peptide for 4 days, then with 10 U/ml
Human IL-2 (Sigma) for a further 7 days to expand responsive
clones. Cultures were weaned of IL-2 over a period of 4 days, then
cells were harvested, washed and added to APC plates at 26104
cells/well. The secondary peptides were added at 5 ug/ml, and
cultures were incubated at 37uC, 5% CO2 for 2 days. Cell-free
supernatants were harvested and IFN-c levels were quantified
using the Bovigam kit as described above.
Human Subjects
Samples were obtained from persons older than 21 years
attending the Voluntary Counselling and Testing (VCT) services
run by the Ubuntu clinic in Khayelitsha site B. Khayelitsha is
a peri-urban township near Cape Town with a population of over
400,000 and an exceptionally high burden of TB (.1500 per
100,000 in 2005). Study groups were either (i) HIV seronegative
persons with culture confirmed active TB (n = 17) or (ii) HIV
seronegative asymptomatic people (n = 11) with skin test or in vitro
evidence of latent TB infection (LTBI), where LTBI is defined as
a Mantoux test of .10mm as per national guidelines PLUS
a positive reaction to either CFP-10 or ESAT-6 in overnight
ELISpot analysis. Peripheral blood mononuclear cells (PBMC)
were extracted from heparinized whole blood within four hours of
collection. PBMC were separated from the whole blood by Ficoll-
PaqueTM gradient technique and stored in liquid nitrogen until
further analysis.
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ELISpot
The ELISpot assay was performed using the Mabtech
ELISpotPRO kit for human IFN-c kit according to manufacturer’s
instructions. Viable PBMC (2.56105 cells/well) were resuspended
in RPMI with 10% Fetal calf serum and added to the pre-coated
and blocked plates and stimulated with antigens and controls for
16–20 hours at 37uC with 5% CO2. After incubation, the plates
were developed and the number of spots were counted using an
ImmunoSpot 3.2 reader and verified manually. Controls included
monoclonal anti-CD3 provided with the kit, and the EsxAB
peptide cocktail as previously described [51]. A positive response
was defined as $20 SFC/106 PBMC above background.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism V4.0
software. The normality of the data was assessed by the
D’Agostino and Pearson omnibus test. Non-parametric data was
compared using the Mann-Whitney U test. Correlation between
normally distributed data sets was analysed using the Pearson
correlation test, while correlation between non-normally distrib-
uted data was analysed using the Spearman correlation test. P
values ,0.05 were considered to be significant.
Supporting Information
Figure S1 Genomic arrangement of pe/ppe gene pairs associated
with ESX gene clusters. pe/ppe gene pairs occur within (A)
extended ESX regions, (B) upstream of esat-6/cfp-10 homologues
and (C) as isolated gene pairs. pe and ppe genes are indicated by
light and dark blue arrows respectively. cfp-10 and esat-6
homologues are indicated by light and dark grey arrows,
respectively. All other genes are indicated by white arrows. pe/
ppe numbers and esx gene names are indicated to the left of each
region, in the order in which they occur. Strikethrough = pe/ppe
proteins not included in this study. Figure adapted from Gey van
Pittius et al. (2006) BMC Evol. Biol.
(TIF)
Figure S2 Evolutionary relationships between the members of
the PPE protein family. The phylogenetic tree was constructed
from the phylogenetic analyses done on the 180 aa N-terminal
domains of the PPE proteins. The tree was rooted to the outgroup,
Rv3873 (PPE68), shown to be the first PPE insertion into ESX-1.
Arrows indicate orthologues of genes present within the M.
smegmatis genome sequence. Five sublineages (including the PPE-
PPW, PPE-SVP and PPE-MPTR subfamilies) are indicated by
Roman numerals. Grey highlights indicate the proteins selected
for this study. Figure adapted from Gey van Pittius et al. (2006)
BMC Evol. Biol.
(TIF)
Table S1 PE/PPE peptides used for stimulation. Provides
peptide sequence, M. bovis sequence comparison and recognition
data for individual peptides and pools.
(TIF)
Table S2 IFN-c responses to PE/PPE peptide pools in naturally
infected cattle. Whole blood from naturally infected cattle (single
intradermal comparative tuberculin test (SICTT)-positive reactors
from herds known to have bovine tuberculosis as determined by
government veterinarians of the Animal Health Agency) was
stimulated with pools of peptides representing 36 PE/PPE
proteins. IFN-c production was assessed by the ELISA-based
Bovigam assay. IFN-Y responses are expressed as OD450– Nil
antigen well reading (DOD450). Pink highlights indicate positive
responses ($0.1). Green highlights indicate pools eliciting positive
responses in $60% experimentally infected cattle (for compari-
son). ND = not determined (as replicates deviated by .30%).
Briefly, 5 out of the 8 field reactors demonstrated responses to
multiple peptide pools. In those responding, between 8 and 40
pools were recognised per animal, with a total of 37 pools
recognised in 2 or more animals. The small number of animals
demonstrating positive responses precludes robust statistical
analysis. However, there appears to be a similar trend in the set
of pools that are recognised, and we note that of the 11 top-
ranking pools (recognised in .60% of experimentally infected
cattle), all but one were recognised in 2 or more of the naturally
infected animals.
(TIF)
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